Session 29: Continuous and Integrated Bioprocessing
Thursday, July 24, 2014: 2:00 PM-5:30 PM
Regency Ballroom A, Second Floor (St. Louis Hyatt Regency at the Arch)
Conveners:
Clementina Delamonacco - DuPont USA, , and Maitreya J. Dunham - University of Washington, Seattle, WA
Commercial biological production of low value added products imposes a paradigm shift on the biotech industry approach to process design, in order to maintain cost effectiveness. This session will cover state of the art bioprocessing options implementing integrated (both upstream and downstream of the bioconversion step) and continuous operation, from lab to commercial scale. Evolutionary engineering strategies utilizing these continuous systems to improve strain performance or mitigate substrate/product toxicity will also be covered.


2:00 PM
An inexpensive miniature modular turbidostat for characterization and experimental evolution
Chris N. Takahashi1, Aaron W. Miller2, Maitreya J. Dunham2 and Eric Klavins1, (1)Electrical Engineering, University of Washington, Seattle, WA, (2)Genome Sciences, University of Washington, Seattle, WA
2:30 PM
Human Lysozyme Production by Kluyveromyces lactis K7 in Fed-Batch and Continuous Biofilm Reactors
Duygu Ercan and Ali Demirci, Department of Agricultural and Biological Engineering, The Pennsylvania State University, University Park, PA
4:00 PM
Hydrogen production from switchgrass by thermophilic isolates with consolidated bioprocessing capabilities
L.P. Christopher, Center for Bioprocessing Research & Development, South Dakota School of Mines &Technology, Rapid City, SD
5:00 PM
Use of evolutionary engineering for strain development and scale-up studies for carotenoids production in yeast
Katy C. Kao, Luis Reyes and Michelle Olson, Chemical Engineering, Texas A&M, College Station, TX
See more of: Invited Oral Papers